BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23656979)

  • 1. Glucose metabolism after renal transplantation.
    Hecking M; Kainz A; Werzowa J; Haidinger M; Döller D; Tura A; Karaboyas A; Hörl WH; Wolzt M; Sharif A; Roden M; Moro E; Pacini G; Port FK; Säemann MD
    Diabetes Care; 2013 Sep; 36(9):2763-71. PubMed ID: 23656979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
    Yates CJ; Fourlanos S; Colman PG; Cohney SJ
    Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation.
    Shabir S; Jham S; Harper L; Ball S; Borrows R; Sharif A
    Transpl Int; 2013 Mar; 26(3):315-21. PubMed ID: 23279163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation.
    Rosettenstein K; Viecelli A; Yong K; Nguyen HD; Chakera A; Chan D; Dogra G; Lim EM; Wong G; Lim WH
    Transplantation; 2016 Jul; 100(7):1571-9. PubMed ID: 26437275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and insulin secretion in renal transplant recipients with hepatitis C.
    Uchida J; Iwai T; Machida Y; Kuwabara N; Kabei K; Kumada N; Nakatani T
    Transplant Proc; 2013 May; 45(4):1540-3. PubMed ID: 23726615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of pre-diabetes after renal transplantation: a single-centre cohort study in 200 consecutive patients.
    Tillmann FP; Quack I; Schenk A; Grabensee B; Rump LC; Hetzel GR
    Nephrol Dial Transplant; 2012 Aug; 27(8):3330-7. PubMed ID: 22492827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.
    Haidinger M; Werzowa J; Voigt HC; Pleiner J; Stemer G; Hecking M; Döller D; Hörl WH; Weichhart T; Säemann MD
    Trials; 2010 Oct; 11():91. PubMed ID: 20925938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial.
    Van Laecke S; Caluwe R; Huybrechts I; Nagler EV; Vanholder R; Peeters P; Van Vlem B; Van Biesen W
    Ann Transplant; 2017 Aug; 22():524-531. PubMed ID: 28848225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant HbA1c and Glucose Metabolism Parameters in Predicting Posttransplant Diabetes Mellitus and Their Course in the First 6 Months After Living-Donor Renal Transplant.
    Rao N; Rathi M; Sharma A; Ramachandran R; Kumar V; Kohli HS; Gupta KL; Sakhuja V
    Exp Clin Transplant; 2018 Aug; 16(4):446-454. PubMed ID: 29251576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus.
    Chakkera HA; Knowler WC; Devarapalli Y; Weil EJ; Heilman RL; Dueck A; Mulligan DC; Reddy KS; Moss AA; Mekeel KL; Mazur MJ; Hamawi K; Castro JC; Cook CB
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1669-75. PubMed ID: 20558559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation.
    Ravindran VK; Moore RH; Dunseath G; Luzio SD; Owens DR; Baboolal K
    Transplantation; 2009 Jun; 87(12):1870-6. PubMed ID: 19543067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation.
    Tatar E; Kircelli F; Demirci MS; Turan MN; Gungor O; Asci G; Ozkahya M; Ok E; Hoscoskun C; Toz H
    Int Urol Nephrol; 2013 Feb; 45(1):251-8. PubMed ID: 23054321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant.
    Singer J; Aouad LJ; Wyburn K; Gracey DM; Ying T; Chadban SJ
    Transpl Int; 2022; 35():10078. PubMed ID: 35368638
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure.
    Wojtusciszyn A; Mourad G; Bringer J; Renard E
    Diabetes Metab; 2013 Oct; 39(5):404-10. PubMed ID: 23999231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Glucose Tolerance between Kidney Transplant Recipients and Healthy Controls.
    Shimada H; Uchida J; Nishide S; Kabei K; Kosoku A; Maeda K; Iwai T; Naganuma T; Takemoto Y; Nakatani T
    J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31252561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.
    Gelens MACJ; van Hooff JP; Usvyat L; Christiaans MH
    J Diabetes Complications; 2017 Sep; 31(9):1384-1388. PubMed ID: 28720321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus After Liver Transplantation.
    Martínez-Díaz-Guerra G; Guadalix S; Aramendi M; Librizzi S; García E; Jiménez C; Hawkins F
    Horm Metab Res; 2016 May; 48(5):325-30. PubMed ID: 26743527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Risk Factors of Abnormal Glucose Metabolism and New-Onset Diabetes Mellitus after Kidney Transplantation: A Single-Center Retrospective Observational Cohort Study.
    Alfieri C; Favi E; Campioli E; Cicero E; Molinari P; Campise M; Gandolfo MT; Regalia A; Cresseri D; Messa P; Castellano G
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.